
Vaccines targeting common gut bacteria E.coli could reduce rates of colon cancer in countries such as the UK, scientists have suggested.
Researchers from the Wellcome Sanger Institute have suggested higher rates of colorectal, bladder and prostate cancers across industrialised countries could in part be explained by two strains of E.coli which cause high rates of urinary tract infections and bloodstream infections.